Abstract

Biliary cryptosporidiosis caused by Cryptosporidium is life-threatening in immunocompromised individuals, particularly those with acquired immune deficiency syndrome (AIDS), resulting in AIDS cholangiopathy. However, studies of biliary cryptosporidiosis have lagged due to the lack of in vitro models that allow complete pathogen development. Here we describe procedures for the generation of mouse cholangiocyte organoids (Chol-orgs). The Chol-orgs, which expressed stem and biliary cell markers, could be clonally expanded for three months and stored in liquid nitrogen for more than one year. Combined with cell differentiation using the air-liquid interface (ALI) approach, we established a culture system for C. parvum. ALI cultures using Chol-orgs have supported ∼50-fold amplification of the pathogen and generated viable oocysts in vitro. In addition, we analyzed the transcriptome of Chol-ALI cultures infected with the IId subtype of C. parvum to characterize host cell responses. RNA-seq analysis revealed that C. parvum upregulated immune and inflammatory responses and downregulated metabolic and cell proliferation signaling pathways in Chol-orgs. A similar system using bovine cholangiocytes also supported the complete development of C. parvum in vitro. These in vitro models provide convenient methods to study biliary cryptosporidiosis and other hepatic infections and to develop effective therapies for AIDS cholangiopathy.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.